Lung cancer is not a smoker’s disease anymore. It is a breather’s disease, driven by toxic air and environmental exposures.

Qure.ai partners with Microsoft to increase access to its lung cancer detection and management suite in the US: Our Bureau, Bengaluru Thursday, November 20, 2025, 13:40 Hrs [IST] ...

1. Food and Drug Administration. FDA grants traditional approval to tarlatamab-dlle for extensive-stage small-cell lung cancer. FDA. November 19, 2025. Accessed November 19, 2025.

Detailed price information for Icecure Medical Ltd Ord (ICCM-Q) from The Globe and Mail including charting and trades.

Amgen announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage small cell ...

Early detection of lung cancer can drastically improve survival rates. Sponsored by Virginia Mason Franciscan Health.

The sandwich therapy showed a 2-year overall survival rate of 97% and a leukemia-free survival rate of 72% in Ph-negative ...

If everyone eligible had a lung cancer screening, 62,000 lives would be saved over five years, a new study shows.

New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...

New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 Clinical Trials Supported by FDA Fast Track ...

Qure.ai has partnered with Microsoft to onboard its end-to-end lung cancer detection, measurement and management suite onto Microsoft’s Precision Imaging Network. The move is positioned to streamline ...

The collaboration brings Qure.ai’s lung cancer detection and management tools to hospitals and health systems across the USA ...